Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03224299 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation
A Phase 2 study of Preoperative Skin Preparation, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 131
- Enrollment target
- 2
- Study locations
NCT03224299 is a Phase 2 study of Preoperative Skin Preparation that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 131 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT03224299, a Phase 2 study of Preoperative Skin Preparation, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 131 participants
- Enrollment target
- 2
- Study locations
Study Summary
Objective of this study is to compare the antimicrobial properties of an investigational agent to an active control and a negative control when applied to specific body locations. Testing will be performed according to the procedures outlined in the Food and Drug Administration Tentative Final Monograph (TFM) for Effectiveness Testing of a Patient Preoperative Skin Preparation
Conditions Studied
Interventions
- OTHER Saline
- DRUG OCT - clear
- DRUG OCT- tinted
- OTHER ChloraPrep
Study Locations (2)
Montana
- BioScience Laboratories - Bozeman
- BioScience Laboratories - Butte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2017-06-21 |
| Est. Completion | 2017-10-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03224299
The ClinicalTrials.gov registry entry for NCT03224299 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Preoperative Skin Preparation appearing as the primary indexed condition, and to 4 interventions - of which Saline is the first listed.
NCT03224299 reports 2 study locations spanning 1 distinct geographic area - top geographies include Montana.
Frequently Asked Questions
What is clinical trial NCT03224299 about?
NCT03224299 is a clinical study titled "Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation". Objective of this study is to compare the antimicrobial properties of an investigational agent to an active control and a negative control when applied to specific body locations. Testing will be performed according to the procedures outlined in the Food and Drug Administration Tentative Final Monog...
What is the current status of trial NCT03224299?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 131 participants. The study started on 2017-06-21. Estimated completion is 2017-10-03.
What conditions does trial NCT03224299 study?
This clinical trial studies the following conditions: Preoperative Skin Preparation.
What interventions are being tested in trial NCT03224299?
The interventions under investigation include: Saline (OTHER), OCT - clear (DRUG), OCT- tinted (DRUG), ChloraPrep (OTHER).
Who is sponsoring clinical trial NCT03224299?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03224299 being conducted?
This trial has 2 study locations across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.